The Ki-67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki-67 PI requires calculation of Ki-67-positive and Ki-67-negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning-based Ki-67 PI algorithm (KAI) that objectively calculates Ki-67 PI. Our study material consisted of NETs divided into training (n = 39), testing (n = 124), and validation (n = 60) series. All slides were digitized and processed in the Aiforia(R) Create (Aiforia Technologies, Helsinki, Finland) platform. The ICC between the pathologists and the KAI was 0.89. In 46% of the tumors, the Ki-67 PIs calculated by the pathologists and the KAI were the same. In 12% of the...
WOS: 000353774200008PubMed ID: 25412850Ki67 index is now an essential part of classification of panc...
Background: The protein ki67 (pki67) is a marker of tumor aggressiveness, and its expression has bee...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109351/1/cncy21457.pd
Ki-67 assessment is a key step in the diagnosis of neuroendocrine neoplasms (NENs) from all anatomic...
The Ki-67 index is an established prognostic factor in gastrointestinal neuroendocrine tumors (GI-NE...
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare epithelial neoplasms. Grading is...
Abstract Introduction: Studies have shown that the Ki-67 index is a valuable biomarker for the diag...
INTRODUCTION / BACKGROUND: The immunohistochemical expression of the Ki-67 protein is routinely used...
To evaluate the accuracy of the Ki-67 labeling index (LI) as an index of brain tumor proliferation, ...
The World Health Organization (WHO) has clear guidelines regarding the use of Ki67 index in defining...
Many studies have emphasised the importance of Ki-67 labeling index (LI) as the proliferation marker...
Objective: To apply immunohistochemical marker Ki-67 and to check it’s expression in various types...
The Ki-67 labeling index has been found to bear prognostic significance in gastrointestinal neuroend...
Background: Proliferation markers, especially Ki67, are increasingly important in diagnosis and prog...
Introduction: NET (Neuroendocrine Tumours) are a heterogeneous group of tumours. It is important to...
WOS: 000353774200008PubMed ID: 25412850Ki67 index is now an essential part of classification of panc...
Background: The protein ki67 (pki67) is a marker of tumor aggressiveness, and its expression has bee...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109351/1/cncy21457.pd
Ki-67 assessment is a key step in the diagnosis of neuroendocrine neoplasms (NENs) from all anatomic...
The Ki-67 index is an established prognostic factor in gastrointestinal neuroendocrine tumors (GI-NE...
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare epithelial neoplasms. Grading is...
Abstract Introduction: Studies have shown that the Ki-67 index is a valuable biomarker for the diag...
INTRODUCTION / BACKGROUND: The immunohistochemical expression of the Ki-67 protein is routinely used...
To evaluate the accuracy of the Ki-67 labeling index (LI) as an index of brain tumor proliferation, ...
The World Health Organization (WHO) has clear guidelines regarding the use of Ki67 index in defining...
Many studies have emphasised the importance of Ki-67 labeling index (LI) as the proliferation marker...
Objective: To apply immunohistochemical marker Ki-67 and to check it’s expression in various types...
The Ki-67 labeling index has been found to bear prognostic significance in gastrointestinal neuroend...
Background: Proliferation markers, especially Ki67, are increasingly important in diagnosis and prog...
Introduction: NET (Neuroendocrine Tumours) are a heterogeneous group of tumours. It is important to...
WOS: 000353774200008PubMed ID: 25412850Ki67 index is now an essential part of classification of panc...
Background: The protein ki67 (pki67) is a marker of tumor aggressiveness, and its expression has bee...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109351/1/cncy21457.pd